Overview

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Status:
Completed

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

The primary objective is to assess the effects of colestilan on the pharmacokinetic profile of candesartan cilexetil when administered at the same time as, 1 hour before, and 3 hours after the first daily dose of colestilan administered at doses of 5 g three times daily compared to administration of candesartan cilexetil alone, in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Mitsubishi Tanabe Pharma Corporation

Treatments:

Bile Acids and Salts
Candesartan
Candesartan cilexetil